Bourquin et al. demonstrated that in acute megakaryoblastic leukemia (AMKL) patients, altered GATA1 function leads to a failure to repress proliferation-associated genes such as c-MYC, contributing to disease pathology [43]. This evidence concerns the gene GATA1 and acute megakaryoblastic leukemia.